2017 annual financial data
ImmuCell 2017 Operating margin
Direct answer
Operating margin was -2.33%.
Operating income was -243,000 USD and net income was -168,000 USD.
Operating cash flow was 1,175,823 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,431,000 USD
- Operating income
- -243,000 USD
- Net income
- -168,000 USD
- Operating cash flow
- 1,175,823 USD